This study aims to determine concentrations of mercury in facial skin lightening cream according to different price categories (category I: <RM29.99, category II: RM30.00-RM59.99, category III: RM60.00-RM99.99 and category IV: !RM100.00) and their potential health risks to users. Prices of skin lightening creams were determined during a preliminary market survey. Thereafter, twenty samples were purchased from various locations such as cosmetic stalls, beauty shops, pharmacies and street vendors based on their stratified price categories. Samples were extracted using microwave digester and analyzed using cold vapor atomic absorption spectrometry (CV-AAS). Non-carcinogenic chronic health risks for application of facial skin lightening cream were calculated using Dermal Absorption Dose (DAD) and Hazard Quotient (HQ). Concentrations of mercury in samples were less than the United States Food and Drug Administration (USFDA) permitted trace levels (<1 ppm) except for one sample from category III which was manufactured in China. Concentrations of mercury in facial skin lightening creams ranged from not detected to 1.13 mg kg
Introduction
Cosmetics are globally used by both men and women. According to United States Federal Food, Drug, and Cosmetic Act, a cosmetic is defined as articles with intention to be applied to the human body for purpose of beautifying and promoting attractiveness. Although it is regulated for health and safety in most countries, concerns on existence of heavy metals such as mercury, lead, cadmium and arsenic in cosmetics persists. Skin lightening creams may contain active ingredients such as mercury, hydroquinone, and steroids which are highly toxic, especially after prolonged applications (AlSaleh and Al-Doush, 1997) . Skin lightening creams are also known as skin whitening or skin bleaching creams. Its use are popular among dark-skinned women in Africa . Recently, porcelain white skin have become a global trend despite chronic adverse health effects (Ladizinski et al., 2011 ).
Mercury's role in skin-lightening creams is to inhibit the melanin pigment by competing with copper in tyrosinase in leading to a fairer skin tone (Al-Saleh et al., 2004; Engler, 2005) . Mercury is considered by World Health Organization (WHO) as one of the top ten chemicals or groups of chemicals of major public health concern. Mercury exists in various forms: elemental (or metallic) and inorganic and organic (Boyd et al., 2000) . Mercury is a neurotoxicant and is banned in the European Union and numerous African nations (WHO, 2011) . Skin-lightening creams containing inorganic mercury are widely used by dark-skinned people to obtain a lighter skin tone (Al-Saleh and Al-Doush, 1997) .
Mercury exposure during pregnancy can cause serious health effects to a developing fetus including impairment of child's neurologic and cognitive development. Prenatal exposure to mercury is of particular concern due to vulnerability of fetal's central nervous system. Effects on neuro development had been measured as decreasing Intelligent Quotient (IQ) (Dickenson et al., 2013) . Symptoms of mercury poisoning include irritability, shyness, tremors, depression, memory problems, and changes in vision or hearing and numbness and tingling in hands, feet or around mouth (USFDA, 2014) .
Study from Al-Saleh et al. (2009) reported presence of mercury in skin lightening creams and investigated chronic effects on mice.
Results showed highest accumulation of mercury in ovaries of mice depending on frequency of cream applications. This could lead to alteration of reproductive behavior resulting in ovarian failures. Thus, mercury pose a significant threat to human's well-being.
To date, there has been no study reporting possible chronic health risk due to mercury contaminated facial skin lightening creams in Malaysia. This study aims to determine concentration of mercury in facial skin lightening creams available in Malaysia's market as well as to assess its potential health risks.
Materials and method

Sampling method
Preliminary survey was conducted on availability, prices and trade names of facial skin lightening creams sold in the Malaysian market. Thereafter, prices are stratified into four categories (category I: <RM29.99, category II: RM30.00-RM59.99, category III: RM60.00-RM99.99 and category IV: >RM100.00).
For each category, five trade names of facial skin lightening creams were purchased from various locations such as cosmetic stalls, pharmacies, beauty shops and street vendors. Twenty samples were collected via convenient sampling. Overall, this study was carried out between September 2014 and June 2015.
Extraction of samples by using microwave digestion technique
The extraction procedure for this study was adapted according to method ASEAN (2006) and Eltegani et al. (2013) . The digestion procedure was as follows: 0.15e0.20 g of each facial skin lightening cream sample was weighted into a microwave vessel liner. Subsequently, 3 mL of 65% nitric acid and 1 mL of 30% hydrogen peroxide were added into the sample. Liners were placed in vessels and the vessel lids were closed. The vessels were for rest about 15 min to ensure complete reaction. The samples were digested in Microwave Digester PRO (Anton Paar, Graz, Austria) according to the following, the max pressure was 50 bar, the internal temperature limit was 200 C, the power ramp and power hold was 800W and the cooling temperature was 50 C. Vessels were cooled at room temperature. Ultrapure water (Milipore, Vimodrone (MI), Italy) were added into the extracts followed by thorough rinsing of inner wall and lid. Extracts were filtered through Whatman paper No. 1 (Sigma Aldrich, German) into 50 mL volumetric flask and were diluted to 50 mL with ultrapure water.
Sample analysis using cold vapor atomic absorption spectromery (CV-AAS)
Samples were analyzed using Cold Vapor Atomic Absorption Spectrometry (CV-AAS) (VP90 Thermo Scientific, England). Data analyses were performed using SOLAAR Data Station V11.02 software from Thermo Electron Corporation. Calibration curve consisted of seven points: 1 ppb, 3 ppb, 5 ppb, 7 ppb, 10 ppb, 15 ppb and 20 ppb.
Quality control (QC)
All glassware were soaked in 5e10% sulphuric acid, washed with detergents, rinsed with ultrapure water and air dried or oven dried prior to use. If the sample concentration was above the range of the calibration standards, it was diluted and re-analyzed. For each batch of sample analysis, a method blank was carried throughout the entire sample preparation and analytical process (USEPA, 1996) . These blanks are useful to determine possible contaminations and carry-overs. The limit of detection (LOD) and limit of quantification (LOQ) were calculated with three and ten times the standard deviation of the 10 individually prepared method blank solution (Khan et al., 2013) . Extraction recovery was evaluated by spiking three replicates of skin lightening cream with mercury standard and compared the concentration of mercury before and after digestion (Zakaria and Ho, 2015) . All samples were analyzed in triplicates.
Statistical analysis
Data was analyzed using Statistical Package for the Social Sciences (SPSS) Version 22. Descriptive statistical parameters such as mean and standard deviation (SD) were used to describe mercury concentrations in facial skin lightening creams. Non-parametric Kruskal Wallis Test was used to determine differences between price categories. All statistical tests were carried out at 5% level of significance (p < 0.05) and two-sided.
Quantitative health risk assessment
There is little information available for calculating a risk assessment of mercury via dermal absorption. Thus, oral reference dose (mg kg À1 day À1 ) (RfD oral ) by fraction of contaminant absorbed in gastrointestinal tract was used to determine the reference dose for this study. It was the sole and best assumption that could be made for dermal absorption of mercury. These calculations were adapted from (Murphy et al., 2009) .
where RfD ABS is the dermal reference dose (mg kg
), RfD oral is the oral mercury Reference Dose (0.0003 mg kg À1 day À1 ) (USEPA, 1992) and ABS GI is the Fraction of contaminant absorbed in the gastrointestinal tract (0.007) (Murphy et al., 2009 ). The RfD ABS in this study was 0.000021 mg kg À1 day À1 by using Eq. (1). The non-carcinogenic chronic health risks are expressed by using the hazard quotient (HQ) in which it is the division of dermal absorbed dose (DAD) with reference dose for absorption (mg kg À1 day À1 ) (RfD ABS ) (USEPA, 1992) .
The HQ level of concern will be set as 1, thus if HQ > 1 indicating there is potential chronic non-carcinogenic health risk.
Mercury can be absorbed through intact skin (Weldon et al., 2000) . The dose absorbed through skin contact was calculated using Eq. (3) (USEPA, 1992) .
where DA event is the absorbed dose per event, EF is the exposure frequency (365 days year À1 ) (Murphy et al., 2009) , ED is the exposure duration (30 years) (Murphy et al., 2009) , EV is the event frequency (1 events day À1 ) (Murphy et al., 2009) , 2004) and ABS is the absorption fraction (0.001) (Murphy et al., 2009 ).
Results and discussion
Quality control
Linear range, linearity, recovery, LOD and LOQ for mercury are shown in Table 1 . The average extraction recovery for mercury was 93.6%. The seven-point calibration curve showed good linearity over the concentration range from 1 to 20 ppb, where correlation coefficient (R 2 ) was 0.999.
Concentration of mercury in facial skin lightening creams
The price category, manufacturing country, cream appearance, mercury concentration DA event , DAD and hazard quotient of facial skin lightening creams are described in Table 2 .
Based on Table 2 , frequency of detection for mercury was 9 out of 20 samples. Most samples have no detectable mercury concentration or have concentration below method quantification limit of 0.001 mg kg
À1
. Mercury quantified in samples was in trace amount. Some mercury elements may have been vaporized during the extraction or during transfer into new containers as mercury is slightly volatile at room temperatures and significantly more volatile when heated (ASTDR, 1999) .
The highest mean concentration of mercury across all price categories was 1.13 mg kg
. This product was manufactured in China and fell within price category III. Most of these products were manufactured in Malaysia and Thailand. Previous studies focused on the mercury content in skin lightening creams samples showed higher range of mercury concentration compared to this study (Peregrino et al., 2011; McKelvey et al., 2011; Murphy et al., 2009) .
Based on Table 2 , overall concentrations of mercury in this study fall below the allowable limit by USFDA except for one China manufactured product from category III. In accordance to Malaysia regulation, a product should be recalled if it poses any risk to consumer (NPCB, 2009) . Therefore, the distributing company could be instructed to immediately halt sales and supplies of the product and remove all physical stocks from the market within 72 h (NPCB, 2013). As such, the product detected with high concentration of mercury in this study should consider to investigate and withdraw from the market if it is found to be stipulated under Degree II (products with minor health risks or substandard) of Guidelines for Control of Cosmetic Products in Malaysia (NPCB, 2009 . The value is also higher than concentration of mercury found in this study. Another study, Mckelvey et al. (2011) reported 8 skin creams with concentrations ranging from 3.37 to 41 600 mg g À1 . According to USFDA (2014) , all other cosmetics containing mercury are adulterated and subject to regulatory action unless it occurs in trace amount of less than 1 part per million (0.0001 percent); as its presence is unavoidable given good manufacturing practice (21 CFR 700.13). However, regulations in USFDA (2014) may not be pertinent to regulations in countries that conducted the product survey regarding the permissible concentration of mercury.
Several literature reported disease associated with mercury exposure from the uses of skin lightening products. A case study by Oliveira et al. (1987) reported a 46 year old woman who developed membranous nephropathy due to cosmetics. One of the disease factors was due to the use of skin lightening cream consisting of mercury as an ingredient. In addition, Weldon et al. (2000) quantified high concentration of mercury in urine post application of Crema de Belleza-Manning (a Mexican beauty cream). Many women were found seeking medical attention with mercury poisoning related symptoms.
Health risk assessment
The potential non-carcinogenic chronic health risk for each samples of facial skin lightening creams are presented in Table 2 . Based on Table 2 , the HQs for all samples are lower than 1 for 30 years or 10950 days of exposure. This indicate that there is little or no possibility for facial skin lightening creams users to experience non-carcinogenic adverse health effects with continuous application for 30 years. Among the tested samples, sample C4 from price category III has the highest HQ which is 3.64 Â 10 À5 .
The value of DAD and HQ were summarized in Table 2 . Across all the samples, the HQ of mercury was highest in price category III where the product is manufactured in China. However, the product is considered safe as its HQ is lower than 1. The HQ of mercury found in this study is ranging from 6.45 Â 10 À7 to 3.64 Â 10 À5 . However, risk higher than these calculations should be anticipated should products be applied to other parts of the body in addition to ones face.
The RfD for dermal absorption was not available in the current health risk database such as Integrated Risk Information System in United States Environmental Protection Agency, Agency of Toxic Substances and Disease Registry and United States of Food Drugs Administration. Therefore, calculations for dermal RfD were made based on values obtained from previous study (Murphy et al., 2009) . Previous studies also adapted the same formula and values for calculations of health risk assessment for dermal exposure (Sun et al., 2013; Xu et al., 2013) .
In this study, quantitative health risk assessment was conducted based on chronic non-carcinogenic health risk. World Health Organization International Agency for Research on Cancer (IARC) in 1997 classified inorganic mercury compounds as Group 3, "not classifiable as to their carcinogenicity in humans," with insufficient Table 1 Linear range, linearity, recovery, LOD and LOQ for mercury.
Element
Linear range (mg L evidence for carcinogenicity in humans, and limited evidence for carcinogenicity of mercuric chloride in experimental animals (USEPA, 2007) . To the best of our knowledge, chronic health risks for mercury in Malaysia's market facial skin lightening creams were determined for the first time in this study. Xu et al. (2013) conducted chronic health risk assessment for dermal exposure to mercury from streets dust. The study estimated child and adults HQ value to be 1.43 Â 10 À3 and 2.18 Â 10 À3 respectively. Recent study by Sun et al. (2013) focused on the health risk of mercury in kindergarten samples. The result of their study showed mercury concentration ranging from 4.3 Â 10 À4 to 2.17 Â 10 À2 for different area (commercial, residential, etc.) . According to Boyd et al. (2000) , concentration of mercury in skin creams is enhanced naturally due its ability to form complex mercury compounds. Skin lightening cream products also contains other active ingredients. Commonly used ingredients were mercury derivatives, hydroquinone derivatives and topical corticosteroids (Pitch e et al., 2005) . Al-Saleh et al. (2011) tested skin lightening creams and concluded that 10 out of 55 products had hydroquinone and 25 out of 56 samples had cortisone. Combination of these ingredients may pose threats to human's health and well-being. Corticosteroids can produce high rates of cutaneous complication while hydroquinone can cause photosensitizing effect (Mah e et al., 2005) .
Other products such as soap and lipstick were also associated with mercury contamination. Harada et al. (2001) found toilet soaps with mercury ranging from 0.11 Â 10 À3 to 7.40 mg mL . However, these concentrations were lower than permitted limit by USFDA.
The use of inorganic mercury creams in skin lightening is detrimental for health. Elevated mercury levels in hair, blood, and urine were found among its users (Mckelvey et al., 2011) . Mercury is known for its toxicity effect; acute or chronic. These forms of toxicity are closely associated with both organic and inorganic mercury preparations. Acute or chronic exposure to topical mercury salts can result in renal, neurologic, and dermal toxicity (Graeme and Pollack, 1998) .
Furthermore, users of skin lightening creams may experience skin absorption of inorganic mercury via the trans-epidermal and trans-appendageal routes (Chan, 2011) . After absorption, inorganic mercury is distributed to all tissues and can cause renal and other toxicities (ASTDR, 1999) .
Skin care users purchased their skin lightening products from street vendors, cosmetic counters and pharmacies in Malaysia. Prices of the products varies from low (<RM29.99) to high (>RM100.00). There is a constant misconception that higher prices are associated with premium products which are more efficient and safe. Also, cosmetics are out-of-pocket expenditures. As such, we aim to associate product pricing with possible mercury toxicity. With these data, users can make more informed choices.
Results for non-parametric Kruskal Wallis testing on the significant differences between the concentrations of mercury in facial skin lightening creams with different price categories are presented in Table 3 . The p-value form the non-parametric Kruskal Wallis was >0.05. Hence, there was no significant difference between the concentrations of mercury with the price categories. The mean concentrations of mercury according to price categories are distributed in Table 3 . The highest mean from category III was 0.49 mg kg À1 while the lowest mean was 0.01 mg kg À1 from category IV. The p-value was greater than 0.05, which signify that there was no significance different between the concentrations of mercury with different price categories.
Conclusion
This study found that concentrations of mercury in the samples were less than the USFDA permitted trace levels of less than 1 ppm in face cream products with the exception of sample C4 from price category III. There was no significant difference between concentrations of mercury and their price categories. All HQs for mercury was below 1. The possibility to develop non carcinogenic chronic health risk for the use of mercury contaminated facial skin lightening creams was not significant.
